Referencias►
1.
Fiocchi A, Borella E, Riva E, et al. A double-blind clinical trial for the evaluation of the therapeutical effectiveness of a calf thymus derivative (Thymomodulin) in children with recurrent respiratory infections.
Thymus.
1986;8:331 - 339.
2.
Garagiola U, Buzzetti M, Cardella E, et al. Immunological patterns during regular intensive training in athletes: quantification and evaluation of a preventive pharmacological approach.
J Int Med Res. 1995;23:85 - 95.
3.
Cavagni G, Piscopo E, Rigoli E, et al. Food allergy in children: an attempt to improve the effects of the elimination diet with an immunomodulating agent (thymomodulin). A double-blind clinical trial.
Immunopharmacol Immunotoxicol. 1989;11:131 - 142.
4.
Bagnato A, Brovedani P, Comina P, et al. Long-term treatment with thymomodulin reduces airway hyperresponsiveness to methacholine.
Ann Allergy. 1989;62:425 - 428.
5.
Civeira MP, Castilla A, Morte S, et al. A pilot study of thymus extract in chronic non-A, non-B hepatitis.
Aliment Pharmacol Therap. 1989;3:395 - 401.
6.
Bortolotti F, Cadrobbi P, Crivellaro C, et al. Effect of an orally administered thymic derivative, thymomodulin, in chronic type B hepatitis in children.
Curr Ther Res.1988;43:67 - 72.
7.
Galli M, Crocchiolo P, Negri C, et al. Attempt to treat acute type B hepatitis with an orally administered thymic extract (thymomodulin): preliminary results.
Drugs Exp Clin Res. 1985;11:665 - 669.
8.
Raymond RS, Fallon MB, Abrams GA. Oral thymic extract for chronic hepatitis C in patients previously treated with interferon. A randomized, double-blind, placebo-controlled trial.
Ann Intern Med.1998;129:797 - 800.
9.
Skotnicki AB. Therapeutic application of calf thymus extract (TFX).
Med Oncol & Tumor Pharmacother.1989;6:31 - 43.
10.
Leung DY, Hirsch RL, Schneider L, et al. Thymopentin therapy reduces the clinical severity of atopic dermatitis.
J Allergy Clin Immunol. 1990;85:927 - 933.
11.
Beall G, Kruger S, Morales F, et al. A double-blind, placebo-controlled trial of thymostimulin in symptomatic HIV-infected patients.
AIDS. 1990;4:679 - 81.
12.
Harper JI, Mason UA, White TR, et al. A double-blind placebo-controlled study of thymostimulin (TP-1) for the treatment of atopic eczema.
Br J Dermatol.
1991;125:368 - 372.
13.
Roullet E, Cesaro P, Simon-Lavoine N, et al. Nonathymulin treatment of multiple sclerosis: double-blind pilot study.
Acta Neurol Scand. 1989;80:5758.
14.
Fransen L, Anthoons J, Hoogewijs G, et al. Thymopentin treatment in genital warts of long duration.
Cancer Detect Prev.1988;12:503 - 509.
15.
Malaise M, Franchimont P, Hauwaert C, et al. Confirmative study of the effectiveness of thymopentin in active rheumatoid arthritis.
Surv Immunol Res. 1985;4(Suppl 1):87 - 93.
16.
Bolla K, Djawari D, Kokoschka EM, et al. Prevention of recurrences in frequently relapsing herpes labialis with thymopentin. A randomized double-blind placebo-controlled multicenter study.
Surv Immunol Res. 1985;4(Suppl 1):37 - 47.
17.
Norton S. Raw animal tissues and dietary supplements.
N Engl J Med. 2000;343:304 - 305.
18.
Longo F, Lepore L, Agosti E, Panizon F. Evaluation of the effectiveness of thymomodulin in children with recurrent respiratory infections.
Pediatr Med Chir
1988;10:603 - 7.
19.
Vettori G, Lazzaro A, Mazzanti P, Cazzola P. Prevention of recurrent respiratory infections in adults.
Minerva Med
1987;78:1281 - 9.
20.
Genova R, Guerra A. A thymus extract (thymomodulin) in the prevention of childhood asthma.
Pediatr Med Chir
1983;5:395 - 402.
21.
Marzari R, Mazzanti P, Cazzola P, Pirodda E. Perennial allergic rhinitis: prevention of the acute episodes with Thymomodulin.
Minerva Med
1987;78:1675 - 81.
22.
Fiocchi A, Grasso U, Travaglini P, et al. A double blind clinical trials on the effectiveness of a thymic derivative (Thymomodulin) in the treatment of children with atopic dermatitis.
Int J Immunother
1987;3:279 - 84.
